Pediatric and adolescent cancer disparities in the Middle East and North Africa (MENA) region: incidence, mortality, and survival across socioeconomic strata

被引:0
作者
Shukla, Ankita [1 ]
Zeidan, Rouba Karen [1 ]
Saddik, Basema [1 ,2 ,3 ]
机构
[1] Univ Sharjah, Res Inst Med & Hlth Sci, Sharjah, U Arab Emirates
[2] Univ Sharjah, Coll Med, Dept Family & Community Med & Behav Sci, Sharjah, U Arab Emirates
[3] Univ New South Wales, Fac Med, Sch Populat Hlth, Sydney, NSW, Australia
关键词
Incidence; Mortality rate; Mortality-to-incidence ratio; Socio-demographic index; Childhood cancer; MENA region; ACUTE LYMPHOBLASTIC-LEUKEMIA; CHILDHOOD-CANCER; ARAB-WORLD; CHILDREN; ONCOLOGY; CHALLENGES; DIAGNOSIS; COUNTRIES; RISK; RADIATION;
D O I
10.1186/s12889-024-21155-8
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundCancer is one of the leading causes of death in children and adolescents, with a significant concentration in low and middle-income countries. Previous research has identified disparities in cancer incidence and mortality based on a country's level of development. The Middle East and North Africa (MENA) region comprises of countries with heterogeneous income and development levels. This study aims to investigate whether discrepancies in cancer incidence and mortality among children and adolescents exist in countries within the MENA region.Materials and methodsData on cancer incidence and mortality were drawn from the Global Burden of Disease Study (GBD) 2019 for all malignant neoplasms (including non-melanoma skin cancers). The analysis was restricted to children and adolescents aged less than 20 years. Mortality- to-Incidence ratios (MIR) were calculated as a proxy measure of survival for each cancer type and country and Spearman's correlation coefficient measured the association between socio-demographic index (SDI), incidence rates, mortality rates, and MIR.ResultsIn 2019, cancer incidence in the MENA region was 4.82/100,000 population, while mortality rate was 11.65/100,000 population. Cancer incidence and mortality was higher among males compared to females. A marked difference was observed in cancer-related mortality rates between low-income and high-income countries. MIR was higher in low-income countries, particularly for males and specific cancer types such as liver, colon and rectum, brain and central nervous system (CNS) cancers, and non-Hodgkin lymphoma among others. A negative correlation was observed between a country's SDI and MIR (-0.797) and SDI and mortality rates (-0.547) indicating that higher SDI corresponds to lower MIR and lower mortality rates.ConclusionThese findings highlight the need for evidence-based interventions to reduce cancer-related mortality and disease burden among children and adolescents, particularly in low-income countries within the region and for cancer types with the highest mortality rates. Additionally, efforts should focus on establishing registries to provide up-to-date national data on cancer incidence and mortality in countries within the region.
引用
收藏
页数:13
相关论文
共 73 条
  • [1] Lam C.G., Howard S.C., Bouffet E., Pritchard-Jones K., Science and health for all children with cancer, Science, 363, pp. 1182-1186, (2019)
  • [2] White Y., Castle V.P., Haig A., Pediatric oncology in developing countries: challenges and solutions, J Pediatr, 162, pp. 1090-1091, (2013)
  • [3] Goss P.E., Lee B.L., Badovinac-Crnjevic T., Strasser-Weippl K., Chavarri-Guerra Y., St Louis J., Et al., Planning cancer control in Latin America and the Caribbean, Lancet Oncol, 14, pp. 391-436, (2013)
  • [4] Cureall Framework: WHO Global Initiative for Childhood Cancer: Increasing Access, Advancing Quality, saving Lives. World Health Organization, (2021)
  • [5] Rodriguez-Galindo C., Friedrich P., Alcasabas P., Antillon F., Banavali S., Castillo L., Et al., Toward the cure of all children with Cancer through Collaborative efforts: Pediatric Oncology as a global challenge, J Clin Oncol, 33, pp. 3065-3073, (2015)
  • [6] Mojen L.K., Rassouli M., Eshghi P., Sari A.A., Karimooi M.H., Palliative Care for Children with Cancer in the Middle East: a comparative study, Indian J Palliat Care, 23, pp. 379-386, (2017)
  • [7] Znaor A., Eser S., Anton-Culver H., Fadhil I., Ryzhov A., Silverman B.G., Et al., Cancer surveillance in northern Africa, and central and western Asia: challenges and strategies in support of developing cancer registries, Lancet Oncol, 19, pp. e85-e92, (2018)
  • [8] Al-Mulla N.A., Chandra P., Khattab M., Madanat F., Vossough P., Torfa E., Et al., Childhood acute lymphoblastic leukemia in the Middle East and neighboring countries: a prospective multi-institutional international collaborative study (CALLME1) by the Middle East Childhood Cancer Alliance (MECCA), Pediatr Blood Cancer, 61, pp. 1403-1410, (2014)
  • [9] Salim E.I., Moore M.A., Al-Lawati J.A., Al-Sayyad J., Bazawir A., Bener A., Et al., Cancer epidemiology and control in the arab world - past, present and future, Asian Pac J Cancer Prev, 10, pp. 3-16, (2009)
  • [10] Abdul-Sater Z., Shamseddine A., Taher A., Fouad F., Abu-Sitta G., Fadhil I., Et al., Cancer Registration in the Middle East, North Africa, and Turkey: Scope and challenges, JCO Glob Oncol, 7, pp. 1101-1109, (2021)